查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1193271

內窺鏡脊柱手術市場：按產品類型、手術類型、最終用戶分類：2021-2031 年全球機會分析和行業預測

Endoscopic Spinal Surgery Market By Product Type, By Procedure type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 236 Pages | 商品交期: 2-3個工作天內

價格

2021 年全球內窺鏡脊柱手術市場價值 5.369 億美元，到 2031 年將達到 10.9631 億美元，2022 年至 2031 年的複合年增長率為 7.4% 預計

內窺鏡脊柱手術（Endoscopic Spine Surgery，簡稱ESS）是一種手術方法，它使用小於1英寸的非常小的切口和帶有內窺鏡的小管狀系統來清楚地顯示人體的內部器官。 ESS 提供的光學技術的進步、高質量的組織可視化和高效的脊柱成像使這種類型的脊柱手術成為當今許多患者的治療選擇。 另外，該手術屬於微創手術之一，術後恢復快。 此外，此過程使用管狀牽開器和內窺鏡間接觀察內部器官。 此外，手術期間的間接可視化已經取代了許多不同外科專業的傳統直接可視化，進一步增加了對內窺鏡脊柱手術的需求。

根據世界衛生組織 (WHO) 的數據，到 2030 年，全球將有約 10 億老年人，相當於總人口的 12%。 預計未來二十年老年人口的比例將繼續增加。 預計到2050年，世界老年人口將達到16億，佔世界總人口94億的16.7%。 此外，多項研究報告稱，老年人更容易患上與年齡相關的慢性疾病，例如背痛和脊柱關節炎，這可能需要特殊治療。

由於預計老年人口將以這種方式增加，因此對疼痛更小、恢復更快的脊柱內窺鏡手術的需求預計會增加，預計市場在預測期內將進一步擴大。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析

第 4 章內窺鏡脊柱手術市場：按產品類型

  • 概覽
    • 市場規模和預測
  • 內窺鏡
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 內窺鏡設備
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 5 章內窺鏡脊柱手術市場：按手術類型

  • 概覽
    • 市場規模和預測
  • 腔內鏡手術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 層間內窺鏡手術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 後路椎間孔切開術和頸椎間盤切除術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 內窺鏡神經根切斷術
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 6 章內窺鏡脊柱手術市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院和診所
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類
  • 門診手術中心
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：按國家/地區分類

第 7 章內窺鏡脊柱手術市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按產品類型
    • 北美市場規模和預測：按治療類型
    • 北美市場規模和預測：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按產品類型
    • 歐洲市場規模和預測：按治療類型分類
    • 歐洲市場規模和預測：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太地區市場規模和按產品類型預測
    • 亞太地區的市場規模和預測：按治療類型
    • 亞太市場規模和預測：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按產品類型
    • LAMEA 市場規模和預測：按治療類型
    • LAMEA 市場規模和預測：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • DEPUY SYNTHES SPINE, INC.（JOHNSON & JOHNSON）
  • MEDTRONIC PLC.
  • MEDICALTEK CO., LTD.
  • STRYKER CORPORATION
  • ZIMMER BIOMET HOLDINGS, INC.
  • OLYMPUS CORPORATION
  • KARL STORZ SE & CO. KG
  • Richard Wolf GmbH
  • GLOBUS MEDICAL INC.
  • Endovision Co., Ltd.
  • joimax GmbH
Product Code: A31581

The global endoscopic spinal surgery market was valued at $536.9 million in 2021, and is projected to reach $1,096.31 million by 2031, registering a CAGR of 7.4% from 2022 to 2031.

Endoscopic spinal surgery (ESS) is referred to surgical procedure, which utilizes a micro-sized incisions which is less than 1-inch and a small tubular system together with an endoscope to get clear image of the internal organs of the human body. This type of spinal surgeries has now become a choice of treatment for many patients owing to the advances in optics, high quality visualization of tissues, and efficient spinal imaging that is offered by ESS. In addition, this procedure is one of the minimally invasive surgeries that provide patients fastest recovery after the surgery. Furthermore, the surgery involves use of tubular retractors and endoscope, which allows indirect visualization of the internal organs. In addition, indirect visualization during procedures has been replaced the traditional forms of direct visualization across many different surgical specialties, which further increases demand for endoscopic spinal surgery.

According to the World Health Organization (WHO), in 2030, it is anticipated there will be about 1 billion older people worldwide, which is equivalent to 12% of the total population. The share of geriatric population is anticipated to continue to grow in the following 20 years. By 2050, it is estimated that there will be 1.6 billion older people worldwide, representing 16.7% of the total world population of 9.4 billion. In addition, according to several studies, it is reported that geriatric population is more prone to several age-related chronic illnesses such as lower back pain and spinal arthritis that may require special treatment procedures.

This anticipated rise in the number of aged population propel demand for endoscopic spinal surgeries as the treatment option as it is less painful and offers faster recovery, which further leads to expansion of the market during the forecast period.

In addition, there is a rise in cases of the spinal disorders such as ankylosing spondylitis, spinal stenosis, herniated discs, hematoma, degenerative disc disease, vertebral fractures and others. According to the Johns Hopkins Arthritis Center, in the recent population estimates indicate that the prevalence of ankylosing spondylitis (AS) in the U.S. is approximately 0.2-0.5% and based on data from multiple countries, the age- and sex-adjusted incidence of ankylosing spondylitis (AS) is 0.4-14 per 100,000 people. In addition, in a year about 2% of people get a herniated disk. Thus, there is a huge prevalence of spinal disorders around the globe, which also increases demand for endoscopic spinal surgery, thereby boosting adoption of instruments associated with the surgery. This further propels growth of the endoscopic spinal surgery market.

Furthermore, technological advancements in this field have led to increase in adoption of this technique among the healthcare providers and also by the patients. Complexity of spinal surgery causes serious obstacles during the procedure, and can lead to less effective surgery, therefore, to overcome this, huge technological advances have been made by researchers. Moreover, use of 3D endoscopes have reduced the risk of damage and enhanced accuracy of the procedure. For instance, introduction of a highly precise procedure for endoscopic spinal surgery with the combination of four key technologies including 3D analysis, advanced algorithms, patient connection platform, and cross modality image registration developed by Mazor Robotics. In addition, governments and other organizations provide fundings to initiate research and development activities in certain regions to bring development in healthcare facilities. This also accelerates growth of the market.

In addition, factors such as rise in adoption of minimally invasive spinal surgeries, increase in prevalence of spinal disorders, and increase in geriatric population around the globe propel growth of the market. Although there are many factors driving growth of the market, high cost associated with endoscopic spine surgery and lack of adequate reimbursement policies in emerging regions hampers growth of the market.

The endoscopic spinal surgery market is studied on the basis of product type, procedure type, end user, and region. By product type, the market is segmented into endoscopes and endoscopic devices. By procedure type, transforaminal endoscopic procedures, interlaminar endoscopic procedures, endoscopic posterior foraminotomy & cervical discectomy and endoscopic visualized rhizotomy. By end user, it is classified into hospitals & clinics and ambulatory surgical centers. Region wise, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Endovision Co. Ltd, Globus Medical Inc., Jiomax Inc., Johnson & Johnson (Depuy Synthes Spine, Inc.),  Karl Storz Se & Co. Kg, Medtronic Plc., Medicaltek Co., Ltd., Olympus Corporation, Richard Wolf, Stryker Corporation, and Zimmer Biomet Holdings, Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the endoscopic spinal surgery market analysis from 2021 to 2031 to identify the prevailing endoscopic spinal surgery market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the endoscopic spinal surgery market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global endoscopic spinal surgery market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Endoscopes
  • Endoscopic Devices

By Procedure type

  • Transforaminal Endoscopic Procedures
  • Interlaminar Endoscopic Procedures
  • Endoscopic Posterior Foraminotomy and Cervical Discectomy
  • Endoscopic Visualized Rhizotomy

By End User

  • Hospital and Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
    • MEDTRONIC PLC.
    • MEDICALTEK CO., LTD.
    • STRYKER CORPORATION
    • ZIMMER BIOMET HOLDINGS, INC.
    • OLYMPUS CORPORATION
    • KARL STORZ SE & CO. KG
    • Richard Wolf GmbH
    • GLOBUS MEDICAL INC.
    • Endovision Co., Ltd.
    • joimax GmbH

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Endoscopes
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Endoscopic Devices
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country

CHAPTER 5: ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Transforaminal Endoscopic Procedures
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Interlaminar Endoscopic Procedures
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country
  • 5.4 Endoscopic Posterior Foraminotomy and Cervical Discectomy
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market share analysis by country
  • 5.5 Endoscopic Visualized Rhizotomy
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market share analysis by country

CHAPTER 6: ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospital and Clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country

CHAPTER 7: ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product Type
    • 7.2.3 North America Market size and forecast, by Procedure type
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Product Type
      • 7.2.5.1.3 Market size and forecast, by Procedure type
      • 7.2.5.1.4 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Product Type
      • 7.2.5.2.3 Market size and forecast, by Procedure type
      • 7.2.5.2.4 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Product Type
      • 7.2.5.3.3 Market size and forecast, by Procedure type
      • 7.2.5.3.4 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product Type
    • 7.3.3 Europe Market size and forecast, by Procedure type
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Product Type
      • 7.3.5.1.3 Market size and forecast, by Procedure type
      • 7.3.5.1.4 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Product Type
      • 7.3.5.2.3 Market size and forecast, by Procedure type
      • 7.3.5.2.4 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Product Type
      • 7.3.5.3.3 Market size and forecast, by Procedure type
      • 7.3.5.3.4 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Product Type
      • 7.3.5.4.3 Market size and forecast, by Procedure type
      • 7.3.5.4.4 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Key market trends, growth factors and opportunities
      • 7.3.5.5.2 Market size and forecast, by Product Type
      • 7.3.5.5.3 Market size and forecast, by Procedure type
      • 7.3.5.5.4 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Key market trends, growth factors and opportunities
      • 7.3.5.6.2 Market size and forecast, by Product Type
      • 7.3.5.6.3 Market size and forecast, by Procedure type
      • 7.3.5.6.4 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Procedure type
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Product Type
      • 7.4.5.1.3 Market size and forecast, by Procedure type
      • 7.4.5.1.4 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Product Type
      • 7.4.5.2.3 Market size and forecast, by Procedure type
      • 7.4.5.2.4 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Product Type
      • 7.4.5.3.3 Market size and forecast, by Procedure type
      • 7.4.5.3.4 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Product Type
      • 7.4.5.4.3 Market size and forecast, by Procedure type
      • 7.4.5.4.4 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Product Type
      • 7.4.5.5.3 Market size and forecast, by Procedure type
      • 7.4.5.5.4 Market size and forecast, by End User
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Key market trends, growth factors and opportunities
      • 7.4.5.6.2 Market size and forecast, by Product Type
      • 7.4.5.6.3 Market size and forecast, by Procedure type
      • 7.4.5.6.4 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product Type
    • 7.5.3 LAMEA Market size and forecast, by Procedure type
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Product Type
      • 7.5.5.1.3 Market size and forecast, by Procedure type
      • 7.5.5.1.4 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Product Type
      • 7.5.5.2.3 Market size and forecast, by Procedure type
      • 7.5.5.2.4 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Key market trends, growth factors and opportunities
      • 7.5.5.3.2 Market size and forecast, by Product Type
      • 7.5.5.3.3 Market size and forecast, by Procedure type
      • 7.5.5.3.4 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Key market trends, growth factors and opportunities
      • 7.5.5.4.2 Market size and forecast, by Product Type
      • 7.5.5.4.3 Market size and forecast, by Procedure type
      • 7.5.5.4.4 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 MEDTRONIC PLC.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 MEDICALTEK CO., LTD.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 STRYKER CORPORATION
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 ZIMMER BIOMET HOLDINGS, INC.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 OLYMPUS CORPORATION
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 KARL STORZ SE & CO. KG
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Richard Wolf GmbH
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 GLOBUS MEDICAL INC.
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Endovision Co., Ltd.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 joimax GmbH
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 92. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 93. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 94.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): COMPANY SNAPSHOT
  • TABLE 95.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): OPERATING SEGMENTS
  • TABLE 96.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): PRODUCT PORTFOLIO
  • TABLE 97.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): NET SALES
  • TABLE 98.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): KEY STRATERGIES
  • TABLE 99.MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 100.MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 101.MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 102.MEDTRONIC PLC.: NET SALES
  • TABLE 103.MEDTRONIC PLC.: KEY STRATERGIES
  • TABLE 104.MEDICALTEK CO., LTD.: COMPANY SNAPSHOT
  • TABLE 105.MEDICALTEK CO., LTD.: OPERATING SEGMENTS
  • TABLE 106.MEDICALTEK CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 107.MEDICALTEK CO., LTD.: NET SALES
  • TABLE 108.MEDICALTEK CO., LTD.: KEY STRATERGIES
  • TABLE 109.STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 110.STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 111.STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 112.STRYKER CORPORATION: NET SALES
  • TABLE 113.STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 114.ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
  • TABLE 115.ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
  • TABLE 116.ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
  • TABLE 117.ZIMMER BIOMET HOLDINGS, INC.: NET SALES
  • TABLE 118.ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGIES
  • TABLE 119.OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 120.OLYMPUS CORPORATION: OPERATING SEGMENTS
  • TABLE 121.OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 122.OLYMPUS CORPORATION: NET SALES
  • TABLE 123.OLYMPUS CORPORATION: KEY STRATERGIES
  • TABLE 124.KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 125.KARL STORZ SE & CO. KG: OPERATING SEGMENTS
  • TABLE 126.KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 127.KARL STORZ SE & CO. KG: NET SALES
  • TABLE 128.KARL STORZ SE & CO. KG: KEY STRATERGIES
  • TABLE 129.RICHARD WOLF GMBH: COMPANY SNAPSHOT
  • TABLE 130.RICHARD WOLF GMBH: OPERATING SEGMENTS
  • TABLE 131.RICHARD WOLF GMBH: PRODUCT PORTFOLIO
  • TABLE 132.RICHARD WOLF GMBH: NET SALES
  • TABLE 133.RICHARD WOLF GMBH: KEY STRATERGIES
  • TABLE 134.GLOBUS MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 135.GLOBUS MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 136.GLOBUS MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 137.GLOBUS MEDICAL INC.: NET SALES
  • TABLE 138.GLOBUS MEDICAL INC.: KEY STRATERGIES
  • TABLE 139.ENDOVISION CO., LTD.: COMPANY SNAPSHOT
  • TABLE 140.ENDOVISION CO., LTD.: OPERATING SEGMENTS
  • TABLE 141.ENDOVISION CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 142.ENDOVISION CO., LTD.: NET SALES
  • TABLE 143.ENDOVISION CO., LTD.: KEY STRATERGIES
  • TABLE 144.JOIMAX GMBH: COMPANY SNAPSHOT
  • TABLE 145.JOIMAX GMBH: OPERATING SEGMENTS
  • TABLE 146.JOIMAX GMBH: PRODUCT PORTFOLIO
  • TABLE 147.JOIMAX GMBH: NET SALES
  • TABLE 148.JOIMAX GMBH: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ENDOSCOPIC SPINAL SURGERY MARKET SEGMENTATION
  • FIGURE 2.ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031
  • FIGURE 3.ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ENDOSCOPIC SPINAL SURGERY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.ENDOSCOPIC SPINAL SURGERY MARKET,BY PRODUCT TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPIC DEVICES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 15.ENDOSCOPIC SPINAL SURGERY MARKET,BY PROCEDURE TYPE,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF TRANSFORAMINAL ENDOSCOPIC PROCEDURES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF INTERLAMINAR ENDOSCOPIC PROCEDURES ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ENDOSCOPIC VISUALIZED RHIZOTOMY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 20.ENDOSCOPIC SPINAL SURGERY MARKET,BY END USER,2021(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HOSPITAL AND CLINICS ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031(%)
  • FIGURE 23.ENDOSCOPIC SPINAL SURGERY MARKET BY REGION,2021
  • FIGURE 24.U.S. ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 25.CANADA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 26.MEXICO ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 27.GERMANY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 28.FRANCE ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 29.UK ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 30.ITALY ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 31.SPAIN ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 32.REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 33.JAPAN ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 34.CHINA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 35.AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 36.INDIA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 37.SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 38.REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 39.BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 40.SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 41.SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 42.REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET,2021-2031($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47.COMPETITIVE DASHBOARD
  • FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 49.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON).: NET SALES ($MILLION)
  • FIGURE 50.MEDTRONIC PLC..: NET SALES ($MILLION)
  • FIGURE 51.MEDICALTEK CO., LTD..: NET SALES ($MILLION)
  • FIGURE 52.STRYKER CORPORATION.: NET SALES ($MILLION)
  • FIGURE 53.ZIMMER BIOMET HOLDINGS, INC..: NET SALES ($MILLION)
  • FIGURE 54.OLYMPUS CORPORATION.: NET SALES ($MILLION)
  • FIGURE 55.KARL STORZ SE & CO. KG.: NET SALES ($MILLION)
  • FIGURE 56.RICHARD WOLF GMBH.: NET SALES ($MILLION)
  • FIGURE 57.GLOBUS MEDICAL INC..: NET SALES ($MILLION)
  • FIGURE 58.ENDOVISION CO., LTD..: NET SALES ($MILLION)
  • FIGURE 59.JOIMAX GMBH.: NET SALES ($MILLION)